COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,633 Articles (22,913 medRxiv, 8,720 bioRxiv)

Most recent first Previous |  Page 1777: Articles 17761-17770  | Next

Decisive Conditions for Strategic Vaccination against SARS-CoV-2
Böttcher, L., Nagler, J.
10.1101/2021.03.05.21252962 — Posted: 2021-03-08
Higher COVID-19 vaccination rates are linked to decreased county-level COVID-19 incidence across USA
Puranik, A., Venkatakrishnan, A., Pawlowski, C., Raghunathan, B., Ramudu, E., Lenehan, P., Agarwal, V., Jayaram, S., Choudhary, M., Soundararajan, V.
10.1101/2021.03.05.21252946 — Posted: 2021-03-08
Serological surveys to estimate cumulative incidence of SARS-CoV-2 infection in adults (Sero-MAss study), Massachusetts, July-August 2020
Snyder, T., Ravenhurst, J., Cramner, E., Reich, N., Balzer, L. B., Alfandari, D., Lover, A. A.
10.1101/2021.03.05.21249174 — Posted: 2021-03-08
High seroprevalence of anti-SARS-CoV-2 antibodies after the first wave of the COVID-19 pandemic in a vulnerable population in Perpignan, France
Beaumont, A., Durand, C., Ledrans, M., Schwoebel, V., Noel, H., Le Strat, Y., Diulius, D., Colombain, L., Medus, M., Gueudet, P., Mouly, D., Aumaitre, H.
10.1101/2021.03.05.21252835 — Posted: 2021-03-08
The COVIDome Explorer Researcher Portal
Sullivan, K. D., Galbraith, M. D., Kinning, K. T., Bartsch, K., Levinsky, N., Araya, P., Smith, K. P., Granrath, R. E., Shaw, J. R., Baxter, R., Jordan, K. R., Russell, S., Dzieciatkowska, M., Reisz, J. A., Gamboni, F., Cendali, F., Ghosh, T., Monte, A. A., Bennett, T. D., Miller, M. G., Hsieh, E. W. Y., D'Alessandro, A., Hansen, K. C., Espinosa, J. M.
10.1101/2021.03.04.21252945 — Posted: 2021-03-08
Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England
Grint, D. J., Wing, K., Williamson, E., McDonald, H. I., Bhaskaran, K., Evans, D., Evans, S. J., Walker, A. J., Hickman, G., Nightingale, E., Schultze, A., Rentsch, C. T., Bates, C., Cockburn, J., Curtis, H. J., Morton, C. E., Bacon, S., Davy, S., Wong, A. Y., Mehrkar, A., Tomlinson, L., Douglas, I. J., Mathur, R., Blomquist, P., McKenna, B., Ingelsby, P., Croker, R., Parry, J., Hester, F., Harper, S., DeVito, N. J., Hulme, W., Tazare, J., Goldacre, B., Smeeth, L., Eggo, R. M.
10.1101/2021.03.04.21252528 — Posted: 2021-03-08 Discussion: Onsite
SARS-CoV-2-specific T Cell Memory is Sustained in COVID-19 Convalescents for 8 Months with Successful Development of Stem Cell-like Memory T Cells
Shin, E.-C., Jung, J. H., Rha, M.-S., Sa, M., Choi, H. K., Jeon, J. H., Seok, H., Park, D. W., Park, S.-H., Jeong, H. W., Choi, W. S.
10.1101/2021.03.04.21252658 — Posted: 2021-03-08
Covid-19 in the California State Prison System: An Observational Study of Decarceration, Ongoing Risks, and Risk Factors
Chin, E. T., Ryckman, T., Prince, L., Leidner, D., Alarid-Escudero, F., Andrews, J. R., Salomon, J. A., Studdert, D. M., Goldhaber-Fiebert, J. D.
10.1101/2021.03.04.21252942 — Posted: 2021-03-08
A single-center retrospective cohort study of Covid-19 medications: Remdesivir, Favipiravir, Methylprednisolone, Dexamethasone, and Interferon β1a and their combinations
Tehrani Fateh, S., Tehrani Fateh, S., Salehi, E., Rezai, N., Haririan, N., Asgari, A., Salehi-Najafabadi, A.
10.1101/2021.03.05.21251351 — Posted: 2021-03-08
SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: Implications for microclot formation in COVID-19
Grobbelaar, L. M., Venter, C., Vlok, M., Ngoepe, M., Laubscher, G. J., Lourens, P. J., Steenkamp, J., Kell, D. B., Pretorius, E., Kell, D. B.
10.1101/2021.03.05.21252960 — Posted: 2021-03-08 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).